Teligent PE Ratio 2010-2021 | TLGT
Current and historical p/e ratio for Teligent (TLGT) from 2010 to 2021. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Teligent PE ratio as of January 23, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Teligent PE Ratio Historical Data |
| Date |
Stock Price |
TTM Net EPS |
PE Ratio |
| 2021-10-15 |
0.17 |
|
0.00 |
| 2021-06-30 |
0.53 |
$-0.19 |
0.00 |
| 2021-03-31 |
0.62 |
$-2.61 |
0.00 |
| 2020-12-31 |
0.75 |
$-7.64 |
0.00 |
| 2020-09-30 |
0.72 |
$-8.64 |
0.00 |
| 2020-06-30 |
2.42 |
$-9.86 |
0.00 |
| 2020-03-31 |
2.80 |
$-8.10 |
0.00 |
| 2019-12-31 |
4.26 |
$-4.70 |
0.00 |
| 2019-09-30 |
9.50 |
$-6.40 |
0.00 |
| 2019-06-30 |
6.30 |
$-5.80 |
0.00 |
| 2019-03-31 |
11.60 |
$-8.90 |
0.00 |
| 2018-12-31 |
13.70 |
$-8.20 |
0.00 |
| 2018-09-30 |
39.50 |
$-6.60 |
0.00 |
| 2018-06-30 |
34.60 |
$-7.10 |
0.00 |
| 2018-03-31 |
33.60 |
$-3.40 |
0.00 |
| 2017-12-31 |
36.30 |
$-2.30 |
0.00 |
| 2017-09-30 |
67.10 |
$-2.30 |
0.00 |
| 2017-06-30 |
91.50 |
$-1.60 |
0.00 |
| 2017-03-31 |
78.10 |
$-1.90 |
0.00 |
| 2016-12-31 |
66.10 |
$-2.30 |
0.00 |
| 2016-09-30 |
76.00 |
$-2.40 |
0.00 |
| 2016-06-30 |
71.40 |
$-2.40 |
0.00 |
| 2016-03-31 |
49.00 |
$-2.20 |
0.00 |
| 2015-12-31 |
89.00 |
$-2.00 |
0.00 |
| 2015-09-30 |
65.40 |
$0.10 |
654.00 |
| 2015-06-30 |
63.00 |
$0.60 |
105.00 |
| 2015-03-31 |
81.60 |
$0.80 |
102.00 |
| 2014-12-31 |
88.00 |
$0.80 |
110.00 |
| 2014-09-30 |
93.20 |
$-0.20 |
0.00 |
| 2014-06-30 |
53.10 |
$-0.20 |
0.00 |
| 2014-03-31 |
56.50 |
$-0.20 |
0.00 |
| 2013-12-31 |
30.50 |
$-0.30 |
0.00 |
| 2013-09-30 |
18.20 |
$-0.50 |
0.00 |
| 2013-06-30 |
14.30 |
$-0.90 |
0.00 |
| 2013-03-31 |
17.10 |
$-0.90 |
0.00 |
| 2012-12-31 |
10.40 |
$-1.00 |
0.00 |
| 2012-09-30 |
12.40 |
$-0.80 |
0.00 |
| 2012-06-30 |
10.30 |
$-0.50 |
0.00 |
| 2012-03-31 |
10.90 |
$-0.60 |
0.00 |
| 2011-12-31 |
11.50 |
$-0.70 |
0.00 |
| 2011-09-30 |
11.00 |
$-0.70 |
0.00 |
| 2011-06-30 |
11.10 |
$-1.40 |
0.00 |
| 2011-03-31 |
15.30 |
$-1.80 |
0.00 |
| 2010-12-31 |
16.80 |
$-2.20 |
0.00 |
| 2010-09-30 |
15.10 |
$-2.70 |
0.00 |
| 2010-06-30 |
10.10 |
$-2.40 |
0.00 |
| 2010-03-31 |
7.10 |
$-4.10 |
0.00 |
| 2009-12-31 |
7.80 |
$-4.70 |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.000B |
$0.000B |
|
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
|
